4.8 Article

Outward-facing conformers of LacY stabilized by nanobodies

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1422265112

关键词

membrane transport proteins; fluorescence; major facilitator superfamily

资金

  1. NIH [DK51131, DK069463, GM073210]

向作者/读者索取更多资源

The lactose permease of Escherichia coli (LacY), a highly dynamic polytopic membrane protein, catalyzes stoichiometric galactoside/H+ symport by an alternating access mechanism and exhibits multiple conformations, the distribution of which is altered by sugar binding. We have developed single-domain camelid nanobodies (Nbs) against a LacY mutant in an outward (periplasmic)-open conformation to stabilize this state of the WT protein. Twelve purified Nbs inhibit lactose transport in right-side-out membrane vesicles, indicating that the Nbs recognize epitopes on the periplasmic side of LacY. Stopped-flow kinetics of sugar binding by WT LacY in detergent micelles or reconstituted into proteoliposomes reveals dramatic increases in galactoside-binding rates induced by interaction with the Nbs. Thus, WT LacY in complex with the great majority of the Nbs exhibits varied increases in access of sugar to the binding site with an increase in association rate constants (k(on)) of up to similar to 50-fold (reaching 10(7) M-1.s(-1)). In contrast, with the double-Trp mutant, which is already open on the periplasmic side, the Nbs have little effect. The findings are clearly consistent with stabilization of WT conformers with an open periplasmic cavity. Remarkably, some Nbs drastically decrease the rate of dissociation of bound sugar leading to increased affinity (greater than 200-fold for lactose).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Mapping inhibitory sites on the RNA polymerase of the 1918 pandemic influenza virus using nanobodies

Jeremy R. Keown, Zihan Zhu, Loic Carrique, Haitian Fan, Alexander P. Walker, Itziar Serna Martin, Els Pardon, Jan Steyaert, Ervin Fodor, Jonathan M. Grimes

Summary: Influenza A viruses cause significant burdens to healthcare systems through seasonal epidemics and global pandemics. The viral RNA-dependent RNA polymerase plays a central role in the replication cycle of influenza viruses and is a potential target for antiviral development. By characterizing the inhibitory effect of nanobodies on the 1918 pandemic influenza virus polymerase complex, sensitive sites interfering with polymerase activity in vitro were identified, suggesting them as effective targets for potential influenza antiviral development.

NATURE COMMUNICATIONS (2022)

Meeting Abstract Biochemistry & Molecular Biology

Stabilization of Meta-I Rhodopsin Conformation by a Nanobody

David Salom, Arum Wu, Christopher L. Sander, Els Pardon, Jan Steyaert, Philip D. Kiser, Krzysztof Palczewski

FASEB JOURNAL (2022)

Article Multidisciplinary Sciences

Structural basis of sodium-dependent bile salt uptake into the liver

Kapil Goutam, Francesco S. Ielasi, Els Pardon, Jan Steyaert, Nicolas Reyes

Summary: This study provides molecular insights into the key conformations of NTCP transport cycle and the recognition mechanisms of HBV/HDV receptors. These findings are expected to contribute to the development of liver disease therapies targeting NTCP.

NATURE (2022)

Article Multidisciplinary Sciences

Structure, substrate recognition and initiation of hyaluronan synthase

Finn P. Maloney, Jeremi Kuklewicz, Robin A. Corey, Yunchen Bi, Ruoya Ho, Lukasz Mateusiak, Els Pardon, Jan Steyaert, Phillip J. Stansfeld, Jochen Zimmer

Summary: In this study, we investigated the substrate binding and polymer synthesis of hyaluronan synthase (HAS) using cryo-electron microscopy structures, biochemical analyses, and molecular dynamics simulations. Our findings provide detailed insights into the transmembrane process of HAS, including substrate selection, polymerization, and regulation of hyaluronan synthesis. This research is important for understanding the biosynthesis of acidic extracellular polysaccharides and one of the most abundant glycosaminoglycans in the human body.

NATURE (2022)

Article Biochemistry & Molecular Biology

Snapshots of actin and tubulin folding inside the TRiC chaperonin

John J. Kelly, Dale Tranter, Els Pardon, Gamma Chi, Holger Kramer, Lotta Happonen, Kelly M. Knee, Jay M. Janz, Jan Steyaert, Christine Bulawa, Ville O. Paavilainen, Juha T. Huiskonen, Wyatt W. Yue

Summary: The integrity of a cell's proteome relies on the correct folding of polypeptides, which is facilitated by the chaperonin TCP-1 ring complex (TRiC). Structural studies have provided insights into the architecture and substrate recognition of TRiC, but the fate of substrates inside the TRiC chamber has remained unclear. In this study, cryo-EM was used to determine the structure of endogenous human TRiC with substrates and cochaperone at different folding stages. The findings revealed the positioning of already-folded regions of client proteins at the chamber wall, allowing unstructured regions to achieve their native fold. The substrates engaged with different sections of the chamber during the folding process, while the cochaperone PhLP2A acted as a molecular strut between the substrate and TRiC chamber. These structural snapshots contribute to our understanding of client protein folding within TRiC.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2022)

Article Multidisciplinary Sciences

Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2

Ranjan K. Singh, Ahmed Soliman, Giambattista Guaitoli, Eliza Stoermer, Felix von Zweydorf, Thomas Dal Maso, Asmaa Oun, Laura Van Rillaer, Sven H. Schmidt, Deep Chatterjee, Joshua A. David, Els Pardon, Thomas U. Schwartz, Stefan Knapp, Eileen J. Kennedy, Jan Steyaert, Friedrich W. Herberg, Arjan Kortholt, Christian Johannes Gloeckner, Wim Versees

Summary: Mutations in the LRRK2 gene are a leading cause of Parkinson's disease, while overactivation of LRRK2 is associated with idiopathic form of the disease. Researchers have identified and characterized nanobodies that can bind to different domains of LRRK2 and inhibit or activate its activity. These nanobodies act through an allosteric inhibitor mechanism and provide potential therapeutic strategies for Parkinson's disease.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Biochemistry & Molecular Biology

Cryo-EM Structure of an Atypical Proton-Coupled Peptide Transporter: Di- and Tripeptide Permease C

Maxime Killer, Giada Finocchio, Haydyn D. T. Mertens, Dmitri I. Svergun, Els Pardon, Jan Steyaert, Christian Loew

Summary: Proton-coupled Oligopeptide Transporters (POTs) mediate the uptake of short di- and tripeptides. This study determined the structure of DtpC and provided insights into its ligand specificity using cryogenic electron microscopy (cryo-EM). The research highlights the value of nanobodies for structure determination of low molecular weight integral membrane proteins.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Article Biochemistry & Molecular Biology

Nanobodies targeting LexA autocleavage disclose a novel suppression strategy of SOS-response pathway

Lorenzo Maso, Filippo Vascon, Monica Chinellato, Frederic Goormaghtigh, Pierangelo Bellio, Enrica Campagnaro, Laurence Van Melderen, Maria Ruzzene, Els Pardon, Alessandro Angelini, Giuseppe Celenza, Jan Steyaert, Donatella Tondi, Laura Cendron

Summary: Antimicrobial resistance poses a threat to eradicating infectious diseases and reducing the effectiveness of available treatments. The bacterial SOS pathway is a key mechanism leading to resistance, and inhibiting this pathway may delay the evolution of antimicrobial resistance. In this study, nanobodies that bind to and block the SOS response in Escherichia coli were identified, paving the way for the development of new-generation antibiotic adjuvants for treating bacterial infections.

STRUCTURE (2022)

Article Chemistry, Multidisciplinary

Nanobody Loop Mimetics Enhance Son of Sevenless 1-Catalyzed Nucleotide Exchange on RAS

Kevin Van Holsbeeck, Baptiste Fischer, Simon Gonzalez, Charlene Gadais, Wim Versees, Jose C. Martins, Charlotte Martin, Alexandre Wohlkoenig, Jan Steyaert, Steven Ballet

Summary: RAS proteins play a crucial role in regulating intracellular signaling networks and mutations that stabilize their active state are associated with cancer development. The study investigated the potential of developing peptide mimetics to modulate RAS signaling by mimicking the complementarity-determining region 3 (CDR3) of the regulatory guanine nucleotide exchange factor (GEF) son of sevenless 1 (SOS1). Through optimization and conformational rigidification, CDR3 mimetics with half of the maximal activation potential of Nanobody14 (Nb14) were obtained, demonstrating the feasibility of modulating protein-protein interactions through structural mimicry of a paratope.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Article Multidisciplinary Sciences

Structural basis of purine nucleotide inhibition of human uncoupling protein 1

Scott A. Jones, Prerana Gogoi, Jonathan J. Ruprecht, Martin S. King, Yang Lee, Thomas Zogg, Els Pardon, Deepak Chand, Stefan Steimle, Danielle M. Copeman, Camila A. Cotrim, Jan Steyaert, Paul G. Crichton, Vera Moiseenkova-Bell, Edmund R. S. Kunji

Summary: Mitochondrial uncoupling protein 1 (UCP1) is responsible for the ability of brown adipose tissue in mammals to burn calories as heat for thermoregulation. UCP1 can be activated by fatty acids to generate heat by catalyzing the leakage of protons across the mitochondrial inner membrane. However, purine nucleotides can bind and inhibit UCP1, regulating proton leak through an unknown molecular mechanism. The cryo-electron microscopy structure of the GTP-inhibited state of UCP1 provides insights into the specific interactions and pH dependency of the regulatory mechanism, indicating that inhibitor binding prevents the conformational changes necessary for proton leak.

SCIENCE ADVANCES (2023)

Article Biochemical Research Methods

Bypassing the Need for Cell Permeabilization: Nanobody CDR3 Peptide Improves Binding on Living Bacteria

A. Breine, K. Van Holsbeeck, C. Martin, S. Gonzalez, M. Mannes, E. Pardon, J. Steyaert, H. Remaut, S. Ballet, C. van der Henst

Summary: Membrane interactions greatly influence the mode of action of proteins, cell-penetrating peptides, and antimicrobial peptides. A recent study discovered a nanobody that interacts with the multidrug-resistant bacteria Acinetobacter baumannii, but it only binds to fixed cells. To overcome this limitation, linear peptides corresponding to the complementarity-determining regions (CDR) were synthesized and labeled with fluorescent tags. Microscopy data showed that the CDR3 sequence has clear membrane interactions with living A. baumannii cells, indicating its importance in binding and avoiding cell permeabilization. The cyclization of the peptide with a rigidifying 1,2,3-triazole bridge retained its binding ability and provided proteolytic protection. Overall, this study led to the discovery of novel peptides that bind a multidrug-resistant pathogen.

BIOCONJUGATE CHEMISTRY (2023)

Article Multidisciplinary Sciences

Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain

Arum Wu, David Salom, John D. Hong, Aleksander Tworak, Kohei Watanabe, Els Pardon, Jan Steyaert, Hideki Kandori, Kota Katayama, Philip D. Kiser, Krzysztof Palczewski

Summary: By discovering specific Nbs that bind to the extracellular surface of rhodopsin and modulate the thermodynamics of its activation process, researchers have revealed the secondary structure of Nbs and how they affect GPCR signaling states. Nbs also improve protein misfolding in disease-associated mutant rhodopsin, making them potential therapeutic agents for related diseases.

NATURE COMMUNICATIONS (2023)

Meeting Abstract Biochemistry & Molecular Biology

Development, characterization and engineering of anti-LexA nanobodies as suppressors of the bacterial SOS response

F. Vascon, L. Maso, M. Chinellato, Y. Bouchiba, E. Campagnaro, S. De Felice, F. Goormaghtigh, P. Bellio, G. Cioci, A. Angelini, G. Celenza, S. Barbe, L. Van Melderen, J. Steyaert, E. Pardon, D. Tondi, L. Cendron

FEBS OPEN BIO (2022)

暂无数据